1-2 of 2
Nathalie Montagne, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Azacitidine Overcomes Prognosis Impact of Poor and Very Poor IPSS-Revised in RAEB-2 Patients but Not in AML Patients.

Thomas Cluzeau, MD, PhD, Nicolas Mounier, MD, PhD, Valentine Richez, Jean-Michel Karsenti, MD, Faezeh Legrand, MD, PhD, Lionel Mannone, MD, Henri Vinti, MD, Laurence Legros, MD, PhD, Lauris Gastaud, Antoine Thyss, MD, Georges Garnier, MD, Daniel Re, MD, Nathalie Montagne, MD, Jean Gutnecht, MD, Patrick Auberger, MD, PhD, Sophie Raynaud, Jill-Patrice Cassuto, MD
Journal: Blood
Blood (2012) 120 (21): 2813.
https://doi.org/10.1182/blood.V120.21.2813.2813
Published: 2012
Journal Articles

Total Genomic Loss Detected by High-Density Single Nucleotide Polymorphism Array Is Predictive of Azacitidine Response in Very Poor IPSS-Revised MDS or AML Patients

Thomas Cluzeau, MD, PhD, Chimè€ne Moreilhon, Nicolas Mounier, MD, PhD, Jean-Michel Karsenti, MD, Lionel Mannone, MD, Faezeh Legrand, MD, PhD, Valentine Richez, Lauris Gastaud, Antoine Thyss, MD, Georges Garnier, MD, Daniel Re, MD, Nathalie Montagne, MD, Jean Gutnecht, MD, Patrick Auberger, MD, PhD, Jill-Patrice Cassuto, MD, Sophie Raynaud
Journal: Blood
Blood (2012) 120 (21): 4936.
https://doi.org/10.1182/blood.V120.21.4936.4936
Published: 2012